UPDATE 1-Hedge fund Paulson & Co discloses 6.3 pct stake in Valeant
June 26 New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc .
Feb 16 Capricor Therapeutics Inc
* Provides update on Natriuretic Peptide program
* Elected to terminate license agreement with Mayo Clinic relating to Natriuretic Peptide receptor agonists, including Cenderitide
* Says expect to file an investigation new drug application for CAP-2003 in second half of this year Source text for Eikon: Further company coverage:
* Team CEO Dalton says plans for next cup within weeks (Updates with Italian challenge for next America's Cup)
* Cathay General Bancorp announces extension of end date for Sinopac Bancorp acquisition